Cancer: Clinical Trials

Department of Health and Social Care written question – answered on 30th April 2020.

Alert me about debates like this

Photo of Alex Norris Alex Norris Shadow Minister (Health and Social Care)

To ask the Secretary of State for Health and Social Care, how many cancer-related clinical trials have been (a) cancelled and (b) suspended as a result of the covid-19 outbreak.

Photo of Nadine Dorries Nadine Dorries The Parliamentary Under-Secretary for Health and Social Care

During the COVID-19 outbreak, Medicines and Healthcare products Regulatory Agency (MHRA) guidance requires trial sponsors to notify the MHRA of a temporary halt to a clinical trial when it involves a direct participant safety issue or a medicines supply issue. Trials which end prematurely are required to be notified to the regulator within 15 days of the decision to end the study.

From 1 March 2020 to 22 April 2020 the MHRA has been notified of 10 temporary halts to cancer-related trials of investigational medicinal products which specifically state COVID-19 as the reason for halting. No cancer-related trials of investigational medicinal products were prematurely ended as a result of COVID-19 during this time. It should be noted that end of trial notifications are only required to be submitted to the regulator if the trial has ended in all the territories it was running in.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.